BEAM-101, a genetically modified cell therapy for sickle cell, is designed to turn on HbF to counteract mutated adult ...

MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, announced today that it will present new ...

ShareThe Acting Vice-Chancellor of Yakubu Gowon University, Abuja, formerly UniAbuja, Prof. Patricia Lar has said that ...

FORT CAVAZOS, Texas (FOX 44) – Fort Cavazos families should be fully vaccinated to protect themselves and the community ...

Sickle Cell Disease is the most common inherited blood disorder in the United States, affecting the lives of 100,000 people, ...